<?xml version="1.0"?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2015//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_150101.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1470916</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5090</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.</ArticleTitle>            <Pagination>                <MedlinePgn>1935-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Cellular proteins associated with immunodeficiency viruses were identified by determination of the amino acid sequence of the proteins and peptides present in sucrose density gradient-purified human immunodeficiency virus (HIV)-1, HIV-2, and simian immunodeficiency virus (SIV). beta 2 microglobulin (beta 2m) and the alpha and beta chains of human lymphocyte antigen (HLA) DR were present in virus preparations at one-fifth the concentration of Gag on a molar basis. Antisera to HLA DR, beta 2 m, as well as HLA class I precipitated intact viral particles, suggesting that these cellular proteins were physically associated with the surface of the virus. Antisera to class I, beta 2m, and HLA DR also inhibited infection of cultured cells by both HIV-1 and SIV. The specific, selective association of these cellular proteins in a physiologically relevant manner has major implications for our understanding of the infection process and the pathogenesis of immunodeficiency viruses and should be considered in the design of vaccines.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Arthur</LastName>                    <ForeName>L O</ForeName>                    <Initials>LO</Initials>                    <AffiliationInfo>                        <Affiliation>AIDS Vaccine Program, National Cancer Institute, Frederick Cancer Research and Development Center NCI-FCRDC, MD 21702.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bess</LastName>                    <ForeName>J W</ForeName>                    <Initials>JW</Initials>                    <Suffix>Jr</Suffix>                </Author>                <Author ValidYN="Y">                    <LastName>Sowder</LastName>                    <ForeName>R C</ForeName>                    <Initials>RC</Initials>                    <Suffix>2nd</Suffix>                </Author>                <Author ValidYN="Y">                    <LastName>Benveniste</LastName>                    <ForeName>R E</ForeName>                    <Initials>RE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Mann</LastName>                    <ForeName>D L</ForeName>                    <Initials>DL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Chermann</LastName>                    <ForeName>J C</ForeName>                    <Initials>JC</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Henderson</LastName>                    <ForeName>L E</ForeName>                    <Initials>LE</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>N01-CO-74102</GrantID>                    <Acronym>CO</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015683">Gene Products, gag</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D007106">Immune Sera</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D001613">beta 2-Microglobulin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1992 Dec 18;258(5090):1880-1</RefSource>                <PMID Version="1">1470911</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D016915">AIDS Vaccines</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002499">Centrifugation, Density Gradient</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002851">Chromatography, High Pressure Liquid</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015683">Gene Products, gag</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015497">HIV-1</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015498">HIV-2</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006684">HLA-DR Antigens</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007106">Immune Sera</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008214">Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009500">Neutralization Tests</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015302">Simian immunodeficiency virus</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001613">beta 2-Microglobulin</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>28</Day>                <Hour>19</Hour>                <Minute>15</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2001</Year>                <Month>3</Month>                <Day>28</Day>                <Hour>10</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>28</Day>                <Hour>19</Hour>                <Minute>15</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1470916</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1470923</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2012</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5090</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Brain tumor treatment: significant contributions.</ArticleTitle>            <Pagination>                <MedlinePgn>1960</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Blaese</LastName>                    <ForeName>R M</ForeName>                    <Initials>RM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Culver</LastName>                    <ForeName>K W</ForeName>                    <Initials>KW</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Ishii</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Oldfield</LastName>                    <ForeName>E H</ForeName>                    <Initials>EH</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Ram</LastName>                    <ForeName>Z</ForeName>                    <Initials>Z</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Wallbridge</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016420">Comment</PublicationType>                <PublicationType UI="D016422">Letter</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>EC 2.7.1.21</RegistryNumber>                <NameOfSubstance UI="D013937">Thymidine Kinase</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.2.1.23</RegistryNumber>                <NameOfSubstance UI="D001616">beta-Galactosidase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentOn">                <RefSource>Science. 1992 Jun 12;256(5063):1550-2</RefSource>                <PMID Version="1">1317968</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <GeneSymbolList>            <GeneSymbol>lacZ</GeneSymbol>        </GeneSymbolList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015316">Genetic Therapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012190">Retroviridae</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013937">Thymidine Kinase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001616">beta-Galactosidase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1470923</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1335166</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5090</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Retinoids selective for retinoid X receptor response pathways.</ArticleTitle>            <Pagination>                <MedlinePgn>1944-6</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Retinoids have a broad spectrum of biological activities and are useful therapeutic agents. Their physiological activities are mediated by two types of receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). RARs, as well as several related receptors, require heterodimerization with RXRs for effective DNA binding and function. However, in the presence of 9-cis-retinoic acid, a ligand for both RARs and RXRs, RXRs can also form homodimers. A series of retinoids is reported that selectively activates RXR homodimers but does not affect RAR-RXR heterodimers and thus demonstrates that both retinoid response pathways can be independently activated.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Lehmann</LastName>                    <ForeName>J M</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Center, La Jolla Cancer Research Foundation, La Jolla, CA 92037.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jong</LastName>                    <ForeName>L</ForeName>                    <Initials>L</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Fanjul</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Cameron</LastName>                    <ForeName>J F</ForeName>                    <Initials>JF</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lu</LastName>                    <ForeName>X P</ForeName>                    <Initials>XP</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Haefner</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Dawson</LastName>                    <ForeName>M I</ForeName>                    <Initials>MI</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Pfahl</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA50676</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>P01 CA51993</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018168">Receptors, Retinoic Acid</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D047488">Retinoid X Receptors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012176">Retinoids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>5688UTC01R</RegistryNumber>                <NameOfSubstance UI="D014212">Tretinoin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.3.1.28</RegistryNumber>                <NameOfSubstance UI="D015500">Chloramphenicol O-Acetyltransferase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015500">Chloramphenicol O-Acetyltransferase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D046911">Macromolecular Substances</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015394">Molecular Structure</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011956">Receptors, Cell Surface</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D018168">Receptors, Retinoic Acid</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011993">Recombinant Fusion Proteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D047488">Retinoid X Receptors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012176">Retinoids</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013329">Structure-Activity Relationship</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D014157">Transcription Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014158">Transcription, Genetic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014212">Tretinoin</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>18</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1335166</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1465616</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5089</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.</ArticleTitle>            <Pagination>                <MedlinePgn>1795-8</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Impaired immune responses occur frequently in cancer patients or in tumor-bearing mice, but the mechanisms of the tumor-induced immune defects remain poorly understood. In an in vivo murine colon carcinoma model (MCA-38), animals bearing a tumor longer than 26 days develop CD8+ T cells with impaired cytotoxic function, decreased expression of the tumor necrosis factor-alpha and granzyme B genes, and decreased ability to mediate an antitumor response in vivo. T lymphocytes from tumor-bearing mice expressed T cell antigen receptors that contained low amounts of CD3 gamma and completely lacked CD3 zeta, which was replaced by the Fc epsilon gamma-chain. Expression of the tyrosine kinases p56lck and p59fyn was also reduced. These changes could be the basis of immune defects in tumor-bearing hosts.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mizoguchi</LastName>                    <ForeName>H</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>O'Shea</LastName>                    <ForeName>J J</ForeName>                    <Initials>JJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Longo</LastName>                    <ForeName>D L</ForeName>                    <Initials>DL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Loeffler</LastName>                    <ForeName>C M</ForeName>                    <Initials>CM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>McVicar</LastName>                    <ForeName>D W</ForeName>                    <Initials>DW</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Ochoa</LastName>                    <ForeName>A C</ForeName>                    <Initials>AC</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>N01-CO-74102</GrantID>                    <Acronym>CO</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017252">Antigens, CD3</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016827">Antigens, CD8</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="C494960">Fyn protein, mouse</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="D019860">Lymphocyte Specific Protein Tyrosine Kinase p56(lck)</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="D051076">Proto-Oncogene Proteins c-fyn</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.-</RegistryNumber>                <NameOfSubstance UI="D053804">Granzymes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.-</RegistryNumber>                <NameOfSubstance UI="C509214">Gzmb protein, mouse</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.-</RegistryNumber>                <NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>SY7Q814VUP</RegistryNumber>                <NameOfSubstance UI="D002118">Calcium</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1992 Dec 11;258(5089):1732-3</RefSource>                <PMID Version="1">1465609</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017252">Antigens, CD3</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016827">Antigens, CD8</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002118">Calcium</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D003110">Colonic Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D003602">Cytotoxicity, Immunologic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D053804">Granzymes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019860">Lymphocyte Specific Protein Tyrosine Kinase p56(lck)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D046911">Macromolecular Substances</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011505">Protein-Tyrosine Kinases</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011518">Proto-Oncogene Proteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051076">Proto-Oncogene Proteins c-fyn</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011948">Receptors, Antigen, T-Cell</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017452">Receptors, IgG</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012697">Serine Endopeptidases</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015398">Signal Transduction</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016176">T-Lymphocyte Subsets</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014409">Tumor Necrosis Factor-alpha</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1465616</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1465609</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCompleted>        <DateRevised>            <Year>2012</Year>            <Month>06</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5089</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Do tumor-altered T cells depress immune responses?</ArticleTitle>            <Pagination>                <MedlinePgn>1732-3</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Travis</LastName>                    <ForeName>J</ForeName>                    <Initials>J</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016420">Comment</PublicationType>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017252">Antigens, CD3</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="C494960">Fyn protein, mouse</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="D019860">Lymphocyte Specific Protein Tyrosine Kinase p56(lck)</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.2</RegistryNumber>                <NameOfSubstance UI="D051076">Proto-Oncogene Proteins c-fyn</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentOn">                <RefSource>Science. 1992 Dec 11;258(5089):1795-8</RefSource>                <PMID Version="1">1465616</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017252">Antigens, CD3</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D003110">Colonic Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D008213">Lymphocyte Activation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019860">Lymphocyte Specific Protein Tyrosine Kinase p56(lck)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D046911">Macromolecular Substances</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011505">Protein-Tyrosine Kinases</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011518">Proto-Oncogene Proteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051076">Proto-Oncogene Proteins c-fyn</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1465609</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1342792</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCompleted>        <DateRevised>            <Year>2008</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5089</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Polarized debate: EMFs and cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>1724-5</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Stone</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1993 Apr 2;260(5104):13-6</RefSource>                <PMID Version="1">8465191</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D055590">Electromagnetic Phenomena</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D004781">Environmental Exposure</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015451">Leukemia, Lymphocytic, Chronic, B-Cell</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007953">Leukemia, Radiation-Induced</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013548">Sweden</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1342792</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1306067</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCompleted>        <DateRevised>            <Year>2012</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5089</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Gene therapy. Harkin seeks compassionate use of unproven treatments.</ArticleTitle>            <Pagination>                <MedlinePgn>1728</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Thompson</LastName>                    <ForeName>L</ForeName>                    <Initials>L</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D002363">Case Reports</PublicationType>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>E</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1993 Mar 19;259(5102):1678-9</RefSource>                <PMID Version="1">8456290</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D026683">Advisory Committees</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000529">Complementary Therapies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D003550">Cystic Fibrosis</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D035082">Federal Government</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015316">Genetic Therapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D033161">Government Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011057">Politics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <OtherID Source="KIE">38424</OtherID>        <KeywordList Owner="KIE">            <Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword>            <Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword>            <Keyword MajorTopicYN="Y">National Institutes of Health</Keyword>            <Keyword MajorTopicYN="N">Recombinant DNA Advisory Committee</Keyword>            <Keyword MajorTopicYN="N">U.S. Congress</Keyword>        </KeywordList>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: gene therapy</GeneralNote>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: human experimentation/regulation</GeneralNote>        <GeneralNote Owner="KIE">News</GeneralNote>        <GeneralNote Owner="KIE">Full author name: Thompson, Larry</GeneralNote>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1306067</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1299224</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>21</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5089</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.</ArticleTitle>            <Pagination>                <MedlinePgn>1792-5</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Mice transgenic for the human T cell leukemia virus (HTLV-I) Tax gene develop fibroblastic tumors that express NF-kappa B-inducible early genes. In vitro inhibition of NF-kappa B expression by antisense oligodeoxynucleotides (ODNs) inhibited growth of these culture-adapted Tax-transformed fibroblasts as well as an HTLV-I-transformed human lymphocyte line. In contrast, antisense inhibition of Tax itself had no apparent effect on cell growth. Mice treated with antisense to NF-kappa B ODNs showed rapid regression of transplanted fibrosarcomas. This suggests that NF-kappa B expression may be necessary for the maintenance of the malignant phenotype and provides a therapeutic approach for HTLV-I-associated disease.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kitajima</LastName>                    <ForeName>I</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shinohara</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Bilakovics</LastName>                    <ForeName>J</ForeName>                    <Initials>J</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Brown</LastName>                    <ForeName>D A</ForeName>                    <Initials>DA</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>X</ForeName>                    <Initials>X</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Nerenberg</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA50234</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>MH47680</GrantID>                    <Acronym>MH</Acronym>                    <Agency>NIMH NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>NS01330</GrantID>                    <Acronym>NS</Acronym>                    <Agency>NINDS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D009838">Oligodeoxyribonucleotides</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="ErratumIn">                <RefSource>Science. 1993 Mar 12;259(5101):1523</RefSource>                <PMID Version="1">8456277</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016475">3T3 Cells</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002455">Cell Division</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002471">Cell Transformation, Neoplastic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005354">Fibrosarcoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D016355">Genes, pX</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015368">Human T-lymphotropic virus 1</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007700">Kinetics</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008214">Lymphocytes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016328">NF-kappa B</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp; inhibitors</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009838">Oligodeoxyribonucleotides</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016376">Oligonucleotides, Antisense</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>11</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1299224</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1360704</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>07</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>07</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5088</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Dec</Month>                        <Day>4</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.</ArticleTitle>            <Pagination>                <MedlinePgn>1650-4</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Cole</LastName>                    <ForeName>S P</ForeName>                    <Initials>SP</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bhardwaj</LastName>                    <ForeName>G</ForeName>                    <Initials>G</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Gerlach</LastName>                    <ForeName>J H</ForeName>                    <Initials>JH</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Mackie</LastName>                    <ForeName>J E</ForeName>                    <Initials>JE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Grant</LastName>                    <ForeName>C E</ForeName>                    <Initials>CE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Almquist</LastName>                    <ForeName>K C</ForeName>                    <Initials>KC</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Stewart</LastName>                    <ForeName>A J</ForeName>                    <Initials>AJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Kurz</LastName>                    <ForeName>E U</ForeName>                    <Initials>EU</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Duncan</LastName>                    <ForeName>A M</ForeName>                    <Initials>AM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Deeley</LastName>                    <ForeName>R G</ForeName>                    <Initials>RG</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <DataBankList CompleteYN="Y">                <DataBank>                    <DataBankName>GENBANK</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>A25059</AccessionNumber>                        <AccessionNumber>A30300</AccessionNumber>                        <AccessionNumber>A34207</AccessionNumber>                        <AccessionNumber>M59076</AccessionNumber>                        <AccessionNumber>M59077</AccessionNumber>                        <AccessionNumber>M60040</AccessionNumber>                        <AccessionNumber>M60041</AccessionNumber>                        <AccessionNumber>M60042</AccessionNumber>                        <AccessionNumber>M69298</AccessionNumber>                        <AccessionNumber>M76128</AccessionNumber>                        <AccessionNumber>M76974</AccessionNumber>                        <AccessionNumber>M83785</AccessionNumber>                        <AccessionNumber>X65054</AccessionNumber>                        <AccessionNumber>X65055</AccessionNumber>                    </AccessionNumberList>                </DataBank>            </DataBankList>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D020168">P-Glycoprotein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>80168379AG</RegistryNumber>                <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1993 May 14;260(5110):879</RefSource>                <PMID Version="1">8098549</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="ErratumIn">                <RefSource>Science. 1993 May 14;260(5110):879</RefSource>                <PMID Version="1">8098549</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002871">Chromosome Banding</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002885">Chromosomes, Human, Pair 16</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004317">Doxorubicin</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004351">Drug Resistance</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005784">Gene Amplification</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008168">Lung</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008562">Membrane Glycoproteins</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005810">Multigene Family</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D020168">P-Glycoprotein</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010802">Phylogeny</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017386">Sequence Homology, Amino Acid</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013737">Testis</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>12</Month>                <Day>4</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>12</Month>                <Day>4</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>12</Month>                <Day>4</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1360704</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1439838</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5087</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Nov</Month>                        <Day>27</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Post-transcriptional regulation of early T cell development by T cell receptor signals.</ArticleTitle>            <Pagination>                <MedlinePgn>1456-62</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>During differentiation in the thymus, immature T cells progress through an ordered sequence of developmental stages that are best characterized by variable expression of the co-receptor molecules CD4 and CD8. Crosslinking of T cell receptor (TCR) molecules on precursor thymocytes was found to block their differentiation into CD4+CD8+ cells by eliminating messenger RNA's encoding two families of developmentally important molecules: the co-receptor molecules CD4 and CD8 and the recombination activating genes 1 and 2. TCR-induced post-transcriptional regulation in early thymocytes was specific for selective messenger RNA's, required protein synthesis, and was itself developmentally regulated. These data identify a post-transcriptional mechanism that is influenced by TCR signals and that regulates early thymocyte development.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Takahama</LastName>                    <ForeName>Y</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Singer</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015704">Antigens, CD4</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016827">Antigens, CD8</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011500">Protein Synthesis Inhibitors</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016693">Receptors, Antigen, T-Cell, alpha-beta</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>NI40JAQ945</RegistryNumber>                <NameOfSubstance UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <GeneSymbolList>            <GeneSymbol>RAG-1</GeneSymbol>            <GeneSymbol>RAG-2</GeneSymbol>        </GeneSymbolList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015704">Antigens, CD4</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016827">Antigens, CD8</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002454">Cell Differentiation</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005333">Fetus</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015329">Gene Rearrangement, T-Lymphocyte</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016654">Genes, RAG-1</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011500">Protein Synthesis Inhibitors</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D011505">Protein-Tyrosine Kinases</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012323">RNA Processing, Post-Transcriptional</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016693">Receptors, Antigen, T-Cell, alpha-beta</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000166">cytology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013755">Tetradecanoylphorbol Acetate</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013950">Thymus Gland</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000196">embryology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>11</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>11</Month>                <Day>27</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>11</Month>                <Day>27</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1439838</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1455234</PMID>        <DateCreated>            <Year>1993</Year>            <Month>01</Month>            <Day>07</Day>        </DateCreated>        <DateCompleted>            <Year>1993</Year>            <Month>01</Month>            <Day>07</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5086</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Nov</Month>                        <Day>20</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Regulation of the differentiation of teratocarcinoma cells into primitive endoderm by G alpha i2.</ArticleTitle>            <Pagination>                <MedlinePgn>1373-5</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>The amount of the heterotrimeric G protein subunit G alpha i2 decreases after the induction of F9 teratocarcinoma cells to become primitive endoderm in the presence of retinoic acid (RA). The reduction of the G alpha i2 protein in F9 cells by antisense RNA expression was associated with (i) loss of receptor-mediated inhibition of adenylyl cyclase; (ii) decreased cell doubling time; (iii) induction of a primitive, endoderm-like phenotype in the absence of RA; and (iv) production of the differentiation marker tissue-type plasminogen activator. Expression of a constitutively active, mutant G alpha i2 blocked RA-induced differentiation. These data suggest the involvement of G alpha i2 in the control of stem cell differentiation and provide insight into the involvement of G proteins in growth regulation.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Watkins</LastName>                    <ForeName>D C</ForeName>                    <Initials>DC</Initials>                    <AffiliationInfo>                        <Affiliation>Diabetes and Metabolic Diseases Research Program, State University of New York, Stony Brook 11794.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Johnson</LastName>                    <ForeName>G L</ForeName>                    <Initials>GL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Malbon</LastName>                    <ForeName>C C</ForeName>                    <Initials>CC</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016372">RNA, Antisense</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>5688UTC01R</RegistryNumber>                <NameOfSubstance UI="D014212">Tretinoin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.5</RegistryNumber>                <NameOfSubstance UI="D013917">Thrombin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.-</RegistryNumber>                <NameOfSubstance UI="D019204">GTP-Binding Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 4.6.1.1</RegistryNumber>                <NameOfSubstance UI="D000262">Adenylate Cyclase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000262">Adenylate Cyclase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002454">Cell Differentiation</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019204">GTP-Binding Proteins</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016372">RNA, Antisense</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013724">Teratoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013917">Thrombin</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014212">Tretinoin</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>11</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1455234</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1439824</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5085</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Nov</Month>                        <Day>13</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.</ArticleTitle>            <Pagination>                <MedlinePgn>1148-52</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Linkage analysis of ten Utah kindreds and one Texas kindred with multiple cases of cutaneous malignant melanoma (CMM) provided evidence that a locus for familial melanoma susceptibility is in the chromosomal region 9p13-p22. The genetic markers analyzed reside in a candidate region on chromosome 9p21, previously implicated by the presence of homozygous deletions in melanoma tumors and by the presence of a germline deletion in an individual with eight independent melanomas. Multipoint linkage analysis was performed between the familial melanoma susceptibility locus (MLM) and two short tandem repeat markers, D9S126 and the interferon-alpha (IFNA) gene, which reside in the region of somatic loss in melanoma tumors. An analysis incorporating a partially penetrant dominant melanoma susceptibility locus places MLM near IFNA and D9S126 with a maximum location score of 12.71. Therefore, the region frequently deleted in melanoma tumors on 9p21 presumably contains a locus that plays a critical role in predisposition to familial melanoma.</AbstractText>            </Abstract>            <AuthorList CompleteYN="N">                <Author ValidYN="Y">                    <LastName>Cannon-Albright</LastName>                    <ForeName>L A</ForeName>                    <Initials>LA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City 84132.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goldgar</LastName>                    <ForeName>D E</ForeName>                    <Initials>DE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Meyer</LastName>                    <ForeName>L J</ForeName>                    <Initials>LJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lewis</LastName>                    <ForeName>C M</ForeName>                    <Initials>CM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Anderson</LastName>                    <ForeName>D E</ForeName>                    <Initials>DE</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Fountain</LastName>                    <ForeName>J W</ForeName>                    <Initials>JW</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Hegi</LastName>                    <ForeName>M E</ForeName>                    <Initials>ME</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Wiseman</LastName>                    <ForeName>R W</ForeName>                    <Initials>RW</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Petty</LastName>                    <ForeName>E M</ForeName>                    <Initials>EM</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Bale</LastName>                    <ForeName>A E</ForeName>                    <Initials>AE</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="N">                <Grant>                    <GrantID>CA 42014</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>CA 48711</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>RR 00064</GrantID>                    <Acronym>RR</Acronym>                    <Agency>NCRR NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>Science. 1992 Nov 13;258(5085):1080-1</RefSource>                <PMID Version="1">1439815</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001483">Base Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002869">Chromosome Aberrations</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002899">Chromosomes, Human, Pair 9</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004416">Dysplastic Nevus Syndrome</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016147">Genes, Tumor Suppressor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005819">Genetic Markers</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008126">Lod Score</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008545">Melanoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010375">Pedigree</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012878">Skin Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013781">Texas</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014589">Utah</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1439824</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1439815</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5085</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Nov</Month>                        <Day>13</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Closing in on melanoma susceptibility gene(s)</ArticleTitle>            <Pagination>                <MedlinePgn>1080-1</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Travis</LastName>                    <ForeName>J</ForeName>                    <Initials>J</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016420">Comment</PublicationType>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentOn">                <RefSource>Science. 1992 Nov 13;258(5085):1148-52</RefSource>                <PMID Version="1">1439824</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D002899">Chromosomes, Human, Pair 9</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008545">Melanoma</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1439815</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1279802</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>23</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5084</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Nov</Month>                        <Day>6</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Tyrosine phosphorylation of CD22 during B cell activation.</ArticleTitle>            <Pagination>                <MedlinePgn>1001-4</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Ligation of the antigen receptor on B cells induces the rapid phosphorylation of tyrosine on a number of cellular proteins. A monoclonal antibody that recognized a tyrosine-phosphorylated cell surface protein that was present in activated B cells was generated. Amino acid sequence analysis showed that this 140-kilodalton protein was CD22, a B cell-specific cell surface glycoprotein and putative extracellular ligand of the protein tyrosine phosphatase CD45. Tyrosine phosphorylation of CD22 may be important in B cell signal transduction, possibly through regulation of the adhesiveness of activated B cells.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Schulte</LastName>                    <ForeName>R J</ForeName>                    <Initials>RJ</Initials>                    <AffiliationInfo>                        <Affiliation>Molecular Biology and Virology Laboratory, Salk Institute, San Diego, CA 92186.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Campbell</LastName>                    <ForeName>M A</ForeName>                    <Initials>MA</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Fischer</LastName>                    <ForeName>W H</ForeName>                    <Initials>WH</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Sefton</LastName>                    <ForeName>B M</ForeName>                    <Initials>BM</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA 14195</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>CA17289</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000944">Antigens, Differentiation, B-Lymphocyte</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C497867">CD22 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D037102">Lectins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D051918">Sialic Acid Binding Ig-like Lectin 2</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>21820-51-9</RegistryNumber>                <NameOfSubstance UI="D019000">Phosphotyrosine</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>42HK56048U</RegistryNumber>                <NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.4.21.1</RegistryNumber>                <NameOfSubstance UI="D002918">Chymotrypsin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015703">Antigens, CD</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000944">Antigens, Differentiation, B-Lymphocyte</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001402">B-Lymphocytes</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002051">Burkitt Lymphoma</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015815">Cell Adhesion Molecules</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002918">Chymotrypsin</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015151">Immunoblotting</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007163">Immunosorbent Techniques</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D037102">Lectins</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D008213">Lymphocyte Activation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010449">Peptide Mapping</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019000">Phosphotyrosine</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D051918">Sialic Acid Binding Ig-like Lectin 2</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014443">Tyrosine</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>11</Month>                <Day>6</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1279802</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1472258</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2012</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5083</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>At age 2, gene therapy enters a growth phase.</ArticleTitle>            <Pagination>                <MedlinePgn>744-6</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Thompson</LastName>                    <ForeName>L</ForeName>                    <Initials>L</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.5.4.4</RegistryNumber>                <NameOfSubstance UI="D000243">Adenosine Deaminase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CitationSubset>X</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="ErratumIn">                <RefSource>Science 1992 Dec 11;258(5089):1719</RefSource>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000163">Acquired Immunodeficiency Syndrome</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000243">Adenosine Deaminase</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000172">deficiency</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004279">DNA, Viral</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015316">Genetic Therapy</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005822">Genetic Vectors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006678">HIV</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D007153">Immunologic Deficiency Syndromes</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012190">Retroviridae</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014162">Transfection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1472258</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1439776</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5083</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>NIH fends off critics of tamoxifen study.</ArticleTitle>            <Pagination>                <MedlinePgn>734</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Stone</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016430">Clinical Trial</PublicationType>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>094ZI81Y45</RegistryNumber>                <NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D005380">Financing, Government</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D013629">Tamoxifen</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1439776</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1439774</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5083</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Breast cancer's forced march?</ArticleTitle>            <Pagination>                <MedlinePgn>732, 734</MedlinePgn>            </Pagination>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Marshall</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016433">News</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>E</CitationSubset>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D035843">Biomedical Research</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D001943">Breast Neoplasms</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D035082">Federal Government</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005380">Financing, Government</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008119">Lobbying</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009316">National Institutes of Health (U.S.)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012109">Research Support as Topic</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000191">economics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D040841">Resource Allocation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <OtherID Source="KIE">37976</OtherID>        <KeywordList Owner="KIE">            <Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword>            <Keyword MajorTopicYN="Y">Department of the Army</Keyword>            <Keyword MajorTopicYN="N">National Cancer Institute</Keyword>            <Keyword MajorTopicYN="N">National Institutes of Health</Keyword>            <Keyword MajorTopicYN="Y">U.S. Congress</Keyword>        </KeywordList>        <GeneralNote Owner="KIE">KIE BoB Subject Heading: biomedical research</GeneralNote>        <GeneralNote Owner="KIE">News</GeneralNote>        <GeneralNote Owner="KIE">Full author name: Marshall, Eliot</GeneralNote>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1439774</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1359641</PMID>        <DateCreated>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>12</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2013</Year>            <Month>11</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5083</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.</ArticleTitle>            <Pagination>                <MedlinePgn>818-21</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Comparative genomic hybridization produces a map of DNA sequence copy number as a function of chromosomal location throughout the entire genome. Differentially labeled test DNA and normal reference DNA are hybridized simultaneously to normal chromosome spreads. The hybridization is detected with two different fluorochromes. Regions of gain or loss of DNA sequences, such as deletions, duplications, or amplifications, are seen as changes in the ratio of the intensities of the two fluorochromes along the target chromosomes. Analysis of tumor cell lines and primary bladder tumors identified 16 different regions of amplification, many in loci not previously known to be amplified.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kallioniemi</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, University of California, San Francisco 94143.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kallioniemi</LastName>                    <ForeName>O P</ForeName>                    <Initials>OP</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Sudar</LastName>                    <ForeName>D</ForeName>                    <Initials>D</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Rutovitz</LastName>                    <ForeName>D</ForeName>                    <Initials>D</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Gray</LastName>                    <ForeName>J W</ForeName>                    <Initials>JW</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Waldman</LastName>                    <ForeName>F</ForeName>                    <Initials>F</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Pinkel</LastName>                    <ForeName>D</ForeName>                    <Initials>D</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA 44768</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>CA 45919</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>CA 47537</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015342">DNA Probes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004273">DNA, Neoplasm</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012235">Rhodamines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>I223NX31W9</RegistryNumber>                <NameOfSubstance UI="D016650">Fluorescein-5-isothiocyanate</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002874">Chromosome Mapping</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015342">DNA Probes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004273">DNA, Neoplasm</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016650">Fluorescein-5-isothiocyanate</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005456">Fluorescent Dyes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D005784">Gene Amplification</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017353">Gene Deletion</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D017404">In Situ Hybridization, Fluorescence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D009693">Nucleic Acid Hybridization</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009857">Oncogenes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012150">Polymorphism, Restriction Fragment Length</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D012235">Rhodamines</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells, Cultured</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1359641</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1411570</PMID>        <DateCreated>            <Year>1992</Year>            <Month>11</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>11</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5082</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>23</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Multistep carcinogenesis: a 1992 perspective.</ArticleTitle>            <Pagination>                <MedlinePgn>603-7</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Cancer is the leading cause of death in Japan. Recent changes in cancer incidence patterns may reflect the trend toward a more Western diet and life-style. Among the dietary factors that contribute to carcinogenesis are the heterocyclic amines, a group of mutagenic compounds present in cooked meat and fish. Carcinogenesis is a multistep process in which cells accumulate multiple genetic alterations as they progress to a more malignant phenotype. Recognition of the growing number of interacting factors that contribute to carcinogenesis may force reconsideration of current methods of risk assessment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sugimura</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>National Cancer Center, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000588">Amines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D002273">Carcinogens</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D006571">Heterocyclic Compounds</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D009153">Mutagens</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D000588">Amines</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D002273">Carcinogens</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D003043">Cocarcinogenesis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D004032">Diet</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006571">Heterocyclic Compounds</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007564">Japan</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009153">Mutagens</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>                <QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>                <QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>                <QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>            </MeshHeading>        </MeshHeadingList>        <NumberOfReferences>55</NumberOfReferences>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1411570</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Owner="NLM" Status="MEDLINE">        <PMID Version="1">1411569</PMID>        <DateCreated>            <Year>1992</Year>            <Month>11</Month>            <Day>25</Day>        </DateCreated>        <DateCompleted>            <Year>1992</Year>            <Month>11</Month>            <Day>25</Day>        </DateCompleted>        <DateRevised>            <Year>2007</Year>            <Month>03</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0036-8075</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>258</Volume>                    <Issue>5082</Issue>                    <PubDate>                        <Year>1992</Year>                        <Month>Oct</Month>                        <Day>23</Day>                    </PubDate>                </JournalIssue>                <Title>Science (New York, N.Y.)</Title>                <ISOAbbreviation>Science</ISOAbbreviation>            </Journal>            <ArticleTitle>Interleukin-6 and its receptor: a paradigm for cytokines.</ArticleTitle>            <Pagination>                <MedlinePgn>593-7</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Many cytokines and cytokine receptors involved in the regulation of hematopoiesis, immune responses, and inflammation have been identified and characterized at the molecular level. Several characteristic features of cytokines, such as pleiotropy and redundancy, are now more clearly understood on the basis of their molecular structures. Accumulating evidence has demonstrated an intimate link between cytokines and various diseases such as allergy, autoimmune diseases, and cancer. The pathogenesis of these diseases and therapies to treat them will be discussed based on insights derived from cytokine research.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kishimoto</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Internal Medicine III, Osaka University Medical School, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Akira</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Taga</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>UNITED STATES</Country>            <MedlineTA>Science</MedlineTA>            <NlmUniqueID>0404511</NlmUniqueID>            <ISSNLinking>0036-8075</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019947">Receptors, Interleukin-6</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D016207">Cytokines</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D015850">Interleukin-6</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="Y" UI="D011971">Receptors, Immunologic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D019947">Receptors, Interleukin-6</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>                <QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>            </MeshHeading>        </MeshHeadingList>        <NumberOfReferences>63</NumberOfReferences>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>1992</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">1411569</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>